With a prevalence of 8.2% in 2004 ([@CIT0001]), diabetes is one of the leading causes of lower limb amputations in Singapore. Diabetes mellitus itself accounts for almost 700 amputations annually ([@CIT0002]). Its devastating complications, including peripheral vascular disease and neuropathy, predispose patients to having diabetic foot infections (DFIs) that most commonly require urgent attention in order to avoid a lower extremity amputation ([@CIT0003]). In the past two decades, publications from Singapore concerning diabetes mellitus underscored the alarming prevalence of its complications in the republic ([@CIT0004]--[@CIT0006]). However, the only studies on DFI in Singapore were undertaken in the 1970s and 1980s ([@CIT0007]--[@CIT0009]). These studies mainly concentrated on the pathophysiology of DFI, such as the defective function of the polymorphonuclear leukocytes and the benefits of maintaining optimal blood glucose levels, along with discussions on criteria for conservative versus ablative surgery. In Singapore, there had been no latest literature studying DFI and predictive factors for limb loss, which would provide an insight to better optimization of patients with DFIs. Our study is the most comprehensive study on DFI undertaken in Singapore recently.

The aim of this study was to evaluate the epidemiology of DFI and to determine its parameters that could be predictive factors for limb loss resulting from major below and above the knee amputations (AKA).

Methods and materials {#S0001}
=====================

This is a prospective study of 100 patients diagnosed and treated with DFI in the National University Hospital of Singapore during the period of January 2005--June 2005. Medical and surgical treatment was provided by our multidisciplinary team approach for the treatment of the diabetic foot. Data on all patients were documented using a carefully designed study protocol. Ethics approval was sought prior to commencement of the study and informed consent was obtained from all subjects studied in this cohort.

Documentation included patient demographics such as age, sex, race and type of DFI (abscess, wet gangrene, infected ulcers, osteomyelitis, necrotizing fasciitis and cellulitis). Objective clinical data such as clinical examination for fever, neuropathy and vasculopathy were also collected. Neuropathy was assessed using the 5.07 Semmes-Weinstein Monofilament Test (SWMT). Ability to detect seven or less sites out of a total of ten sites indicated the presence of peripheral neuropathy. The ankle-brachial index (ABI) measured was used to determine if a patient had vasculopathy. Patients with a recorded ABI value of \<0.8 were considered to have vasculopathy. Laboratory investigations, including glycosylated hemoglobin (HbA1c), erythrocyte sedimentation rate (ESR), hemoglobin level (Hb), white blood cell (WBC) count, creatinine (Cr) and C-reactive protein (CRP) levels were recorded and documented. Blood cultures were performed for all patients and swabs were taken from the local infection sites for culture of aerobic and anaerobic organisms. In patients undergoing debridement or amputation, intra-operative infected tissue was examined for culture and sensitivities.

The treatment administered to each patient was also recorded. Conservative treatment included, but was not limited to intravenous antibiotics, bedside wound debridement and local wound care, whereas surgical treatment included debridement or distal foot amputation versus major below the knee amputation (BKA) or AKA. Patients were considered to have a successful limb salvage procedure when they received conservative treatment only, or had undergone operations such as wound debridement, incision and drainage, and distal amputations such as toe disarticulation and ray amputation. Patients who had undergone major amputations (BKA or AKA) were classified as having a non-salvageable procedure performed. All patients were reviewed weekly or fortnightly for the first two months and subsequently monthly for a minimum of two years.

In this cohort, the following factors were studied to see if they were significant predictive factors of limb loss: age, sex, ethnicity, type of DFI, fever, type of pathogen(s) encountered, presence of neuropathy and vasculopathy, WBC, ESR, CRP, Hb, HbA1c and Cr. All statistical analysis were performed using SPSS 14.0 with statistical significance set at (*P*\< 0.050). Predictive factors for limb loss were determined using univariate and stepwise logistic regression analysis.

Results {#S0002}
=======

The ages of our patients ranged between 21 and 91 years with a mean of 59.8 years. The majority were in their 5th and 6th decades of life (59.0%). Nineteen percent were in their 1st--4th decades of life, and the remaining 22.0% were in their 7th--9th decades of life. The ratio of male to female patients was approximately 1:1. Forty-nine percent of the patients were females and 51% were males. Racial distribution was 46% Chinese, 39% Malays and 15% Indians. In comparison with the national racial distribution of Singapore ([@CIT0010]), which reported 75.6% Chinese, 13.6% Malays and 8.7% Indians, there was a significant increased representation in Malays (*P*\< 0.001) and a significant decreased representation in Chinese (*P*\< 0.001). All patients had type 2 diabetes mellitus for at least 5 years in duration. The most common DFIs were abscess (32%), wet gangrene (29%), infected ulcers (19%) and osteomyelitis (13%). Other infections included necrotizing fasciitis (4%) and cellulitis (3%).

Culture swabs from ulcers or from infected tissues sent for bacterial cultures intra-operatively showed that 48% of the infections were monomicrobial and 52% were polymicrobial. For monomicrobial infections, the most common pathogens were *Staphylococcus aureus* (31.3%), methicillin-resistant *S. aureus* (MRSA) (16.7%) and *Pseudomonas aeruginosa* (16.7%). Other pathogens included *Streptococcus agalactiae* (12.5%), *Bacteroides fragilis* (12.5%), beta-haemolytic *Streptococcus* (4.1%), *Peptostreptococcus* (2.1%) and others (4.1%). For polymicrobial infections, the most common organisms found were *S. aureus* (48.1%), *B*. *fragilis* (46.2%) and *P. aeruginosa* (34.6%). Other pathogens included *S*. *agalactiae* (28.9%), *Peptostreptococcus* (19.2%), beta-haemolytic *Streptococcus* (15.4%), MRSA (13.5%) and others (13.5%). The commonest pathogens found in all infections (both monomicrobial and polymicrobial) were *S. aureus* (39.7%), *B. fragili*s (30.3%), *P. aeruginosa* (26.0%) and *S. agalactiae* (21.0%). Others included MRSA (15.0%), *Peptostreptococcus* (11.0%), beta-haemolytic *Streptococcus* (10.4%) and others (9.6%). Bose ([@CIT0011]) and Frykberg ([@CIT0012]) reported similar findings to our study. They found *S. aureus* to be the most common pathogen as in this study.

With regards to the markers of infection, 62.0% had elevated WBC counts (WBC ≥ 11.0×10^9^), and 38.0% had WBC ≥ 15.0×10^9^/L. Ninety-seven percent had raised ESR (ESR ≥ 16mm/hr for males and ESR ≥ 19 mm/hr for females) and 53.0% had ESR ≥100 mm/hr. Ninety-five percent had elevated CRP (CRP ≥ 1.0 mg/dL) and 26.0% had CRP ≥ 15.0 mg/dL. Seventy-seven percent had reduced Hb levels (Hb ≤ 13.1 g/dL) and 31.0% had Hb ≤ 10.0 g/dL. Thirty-nine percent had elevated Cr levels (Cr ≥ 115 µmol/l) and 29.0% had Cr ≥ 150 µmol/l. The majority (79.0%) of the patients had poor control of diabetes, as indicated by their HbA1c level (\> 7.0%). Fifteen percent of patients had HbA1c\>13.0%. Of the 100 patients documented, 37.0% experienced fever, 67.0% had ABI\<0.8 (indicating vasculopathy), and 84.0% were found to have sensory neuropathy based on SWMT.

All patients had no prior surgical intervention performed for their DFI. The mean follow-up duration was 24 months. This was a single surgeon series, who dictated which procedure to perform and the surgical procedures were not staged. Thirteen patients were treated conservatively with intravenous antibiotics, bedside wound debridement and local wound care. Surgery was required in 87 patients, including 21 ray amputations, 18 debridements, 14 incisions and drainage, 6 toe disarticulations and 28 major amputations (24 BKA and 4 AKA). There were no re-infections or secondary surgical procedures required for patients who underwent surgery. The amputation rate of 28% is much lower than the higher amputation rate of 40% reported by Bose ([@CIT0007]).

Discussion {#S0003}
==========

Predictive factors for lower extremity amputations ([Table 1](#T0001){ref-type="table"}) {#S20004}
----------------------------------------------------------------------------------------

### Age

Thirty-eight percent of patients older than age 60 suffered limb loss in comparison to 18.0% of patients younger than age 60 y. Patients older than age 60 were found to be a significant predictive factor for limb loss (*P*= 0.026), similar to findings by Leung et al. ([@CIT0013]) and Santos et al. ([@CIT0014]).

###### 

Evaluation of factors as predictive factors for limb loss

                                               Limb Loss   Unadjusted   Stepwise analysis                                  
  -------------------------------------- ----- ----------- ------------ ------------------- ---------- ------------------- -------
  *Age*                                                                                                                    
  \>60 years                                   19 (38.0)   31 (62.0)    2.8 (1.1 -- 7.0)    0.029                          
  ≤ 60 years                                   9 (18.0)    41 (82.0)    1.0                                                
                                                                                                                           
  *Gender*                                                                                                                 
  Male                                         12 (23.5)   39 (76.5)    0.6 (0.3-- 1.5)     0.310                          
  Female                                       16 (32.7)   33 (67.3)    1.0                                                
                                                                                                                           
  *Ethnicity*                                                                                                              
  Chinese                                      16 (34.8)   30 (65.2)    2.1 (0.8 -- 5.5)    0.149                          
  Malay                                        8 (20.5)    31 (79.5)    1.0                                                
  Indian                                       4 (26.7)    11 (73.3)    1.4 (0.4 -- 5.6)    0.627                          
                                                                                                                           
  *Type of DFI*                                                                                                            
  Abscess                                                                                                                  
                                         Yes   2 (6.3)     30 (93.8)    0.1 (0.0 -- 0.5)    0.001                          
                                         No    26 (38.2)   42 (61.8)    1.0                                                
  Gangrene                               Yes   17 (58.6)   12 (41.4)    7.7 (2.9 -- 20.6)   \< 0.001   5.6 (1.7 -- 18.7)   0.005
                                         No    11 (15.5)   60 (84.5)    1.0                                                
  Infected Ulcer                         Yes   5 (26.3)    14 (73.7)    0.9 (0.3 -- 2.8)    0.856                          
                                         No    23 (28.4)   58 (71.6)    1.0                                                
  Osteomyelitis                          Yes   2 (15.4)    11 (84.6)    0.4 (0.1 -- 2.1)    0.342                          
                                         No    26 (29.9)   61 (70.1)    1.0                                                
  Necrotising Fasciitis                  Yes   2 (50.0)    2 (50.0)     2.7 (0.4 -- 20.1)   0.312                          
                                         No    26 (27.1)   70 (72.9)    1.0                                                
  Cellulitis                             Yes   0 (0.0)     30(100.0)    NA                  0.557                          
                                         No    28 (38.2)   42 (61.8)    1.0                 0.001                          
                                                                                                                           
  *Complications*                                                                                                          
  Fever                                  Yes   12 (32.4)   25 (67.6)    1.4 (0.6 -- 3.4)    0.449                          
                                         No    16 (25.4)   47 (74.6)    1.0                                                
  ABI\<0.8                               Yes   26 (38.8)   41 (61.2)    9.8 (2.2 -- 44.6)   0.001      19.9 (2.8-139.6)    0.003
                                         No    2 (6.1)     31 (93.9)    1.0                                                
  Neuropathy                             Yes   25 (29.8)   59 (70.2)    1.8 (0.5 -- 7.0)    0.546                          
                                         No    3 (18.8)    13 (81.2)    1.0                                                
                                                                                                                           
  *Type of Pathogens*                                                                                                      
  *Staphylococcus aureus*                Yes   9 (22.5)    31 (77.5)    0.6 (0.3 -- 1.6)    0.317                          
                                         No    19 (31.7)   41 (68.3)    1.0                                                
  *Bacteriodes fragilis*                 Yes   8 (26.7)    22 (73.3)    0.9 (0.4 -- 2.4)    0.846                          
                                         No    20 (28.6)   50 (71.4)    1.0                                                
  *Pseudomonas aeruginosa*               Yes   10 (38.5)   16 (61.5)    1.9 (0.8 -- 5.0)    0.167                          
                                         No    18 (24.3)   56 (75.7)    1.0                                                
  *Streptococcus agalactiae* Group B     Yes   2 (9.5)     19 (90.5)    0.2 (0.1 -- 1.0)    0.034                          
                                         No    26 (32.9)   53 (67.1)    1.0                                                
  MRSA                                   Yes   7 (46.7)    8 (53.3)     2.7 (0.9 -- 8.2)    0.117                          
                                         No    21 (24.7)   64 (75.3)    1.0                                                
  *Peptostreptococcus*                   Yes   2 (18.2)    9 (81.8)     0.5 (0.1 -- 2.7)    0.723                          
                                         No    26 (29.2)   63 (70.8)    1.0                                                
  *Beta- Haemolytic Streptococcus* sp.   Yes   1 (10.0)    9 (90.0)     0.3 (0.0 -- 2.1)    0.275                          
                                         No    27 (30.0)   63 (70.0)    1.0                                                
                                                                                                                           
  Monomicrobial                          Yes   18 (37.5)   30 (62.5)    2.5 (1.0 -- 6.2)    0.042                          
                                         No    10 (19.2)   42 (80.8)    1.0                                                
  Polymicrobial                          Yes   10 (19.2)   42 (80.8)    0.4 (0.2 -- 1.0)    0.042      0.2 (0.1 -- 0.7)    0.010
                                         No    18 (37.5)   30 (62.5)    1.0                                                
                                                                                                                           
  *Markers of Infection*                                                                                                   
  WBC ≥ 15.0 x 10^9^/L                   Yes   16 (42.1)   22 (57.9)    3.0 (1.2 -- 7.5)    0.014      4.7 (1.3 -- 16.8)   0.016
                                         No    12 (19.4)   50 (80.6)    1.0                                                
  ESR ≥ 100 mm/hr                        Yes   22 (41.5)   31 (58.5)    4.8 (1.7 -- 7.5)    0.001                          
                                         No    6 (12.8)    41 (87.2)    1.0                                                
  CRP ≥ 15.0 mg/Dl                       Yes   12 (46.2)   14 (53.8)    3.1 (1.2 -- 8.0)    0.017                          
                                         No    16 (21.6)   58 (78.4)    1.0                                                
  Hb ≤ 10.0 g/dL                         Yes   16 (51.6)   15 (48.4)    5.1 (2.0 -- 13.0)   \< 0.001   5.2 (1.5 -- 17.7)   0.008
                                         No    12 (17.4)   57 (82.6)    1.0                                                
  HbA1C\>7.0%                            Yes   19 (24.1)   60 (75.9)    2.4 (0.9 -- 6.5)    0.093                          
                                         No    9 (42.9)    12 (57.1)    1.0                                                
  Cr≥150 µmol/l                          Yes   15 (51.7)   14 (48.3)    4.8 (1.9 -- 12.3)   0.001                          
                                         No    13 (18.3)   58 (81.7)    1.0                                                

### Gender

Gender was not found to be an important predictive factor for limb loss (*P*= 0.310). This is similar to findings by Miyajima et al. ([@CIT0015]) and Gurlek et al. ([@CIT0016]), although Hamalainen et al ([@CIT0017]) showed otherwise, indicating that the male gender has a higher risk of undergoing lower extremity amputations.

### Ethnicity

Ethnicity was also not a predictive factor for limb loss (*P*\> 0.050) for all three major races in Singapore. This is in contrast to studies conducted in the United States, where Resnick et al. ([@CIT0018]) showed that people of African American descent with diabetes have a much higher amputation risk than whites, as well as studies conducted in the United Kingdom, which showed that African Caribbean men had a lower risk of amputation than European men ([@CIT0019]). In a recent study carried out on a larger cohort of 234 patients, Nather et al., however, have recently reported that the Malay ethnicity, along with a low-level of education and low average household income, were found to have a significantly higher incidence of diabetic foot problems ([@CIT0020]).

### Type of diabetic foot infection

Among the types of DFI present, only gangrene was found to be highly significant as a predictive factor for limb loss (*P*\< 0.001). Approximately 58.6% of cases involving wet gangrene had major amputations. Pittet et al. ([@CIT0021]) also reported a similar finding, although their study showed that in addition to gangrene, plantar ulcers, deep tissue infections and osteomyelitis were also highly significant as predictive factors for limb loss. The significance of gangrene as a predictive factor for limb loss and the lack of significance for other types of DFI indicated urgency to actively treat infections with gangrene.

### Fever

Out of 37 patients presented with fever (temperature ≥ 38°C), twelve had major lower extremity amputations (32.4%). Fever was not found to be a predictive factor for limb loss (*P*= 0.449).

### Neuropathy

Approximately 29.8% of patients with sensory neuropathy had a major amputation in comparison with 18.8% of those without neuropathy who had a major amputation. Neuropathy was not found to be a significant factor in predicting limb loss (*P*= 0. 546). As neuropathy is commonly regarded as a major factor that predisposes diabetic patients to lower extremity amputations, as shown by Reiber et al. ([@CIT0022]) and Hamalainen et al. ([@CIT0017]), it was surprising that neuropathy was not found to be significant in our study.

### ABI measurements

About 38.8% of patients with ABI \<0.8 (indicating vasculopathy) underwent major amputations, in comparison with 6.1% of patients with ABI ≥ 0.8 who had major amputations performed.

The ABI \<0.8 was found to be highly significant in predicting limb loss (*P*= 0.001), similar to findings by Pittet et al. ([@CIT0021]) and Hamalainen et al. ([@CIT0017]). Medial arterial calcinosis (MAC) occurs frequently and unpredictably in diabetic patients, and this may result in non-compressible arteries and artificially elevated ABI. Mayfield et al. ([@CIT0023]) found that MAC is associated with an increased risk of ulceration, amputation and mortality. Hence, one should not be re-assured by a normal ABI in diabetic foot disease.

### Type of pathogen

Approximately 37.5% of patients with monomicrobial infections suffered from limb loss, in contrast to 19.2% of patients with polymicrobial infections. Comparison of monomicrobial versus polymicrobial infections as a predictive factor for limb loss showed that the former was significant (*P*= 0.042). Frykberg ([@CIT0012]) reported in a review that severe infections are characterized by polymicrobial involvement, but our findings showed monomicrobial infections to be significant as a predictive factor of limb loss. When individual pathogens were studied as predictive factors for limb loss, none were found to be predictive of limb loss (*P*\> 0.050). However, Fejfarova et al. ([@CIT0024]) found *S*. *aureus* to be a significant predictive factor for limb loss.

Wheat et al. ([@CIT0025]) has shown that deep-tissue biopsy were likely to contain a single organism, as compared to superficial wound culture, which were more likely to be polymicrobial. Hence, the higher amputation rate in patients having monomicrobial infections could be contributed by the fact that patients with more severe infections often undergo surgical intervention and more likely to have deep tissue (intra-operative) cultures.

Markers of infection {#S20013}
--------------------

### White blood cells ≥ 15.0×10^9^/L

Limb loss occurred in 42.1% of patients with WBC ≥ 15.0×10^9^/L. WBC ≥ 15.0×10^9^/L was found to be a significant predictive factor for limb loss (*P*= 0.014).

### Erythrocyte sedimentation rate ≥ 100 mm/hr

Limb loss occurred in 41.5% of patients with ESR ≥ 100 mm/hr. [Table 1](#T0001){ref-type="table"} showed that ESR ≥ 100 mm/hr was also a significant predictive factor for limb loss (*P*= 0.001)

### C-reactive protein ≥15.0 mg/dL

Limb loss occurred in 46.2% of patients with CRP ≥15.0 mg/dL. CRP ≥15.0 mg/dL was also found to be a significant predictive factor for limb loss (*P*= 0.017).

### Hemoglobin ≤10.0 g/dL

Limb loss occurred in 51.6% of patients with Hb ≤10.0g/dL. It was interesting to note that Hb ≤10.0g/dL was a highly significant predictive factor for limb loss (*P*\< 0.001).

### Creatinine ≥150 µmol/l

Limb loss occurred in 51.7% of patients with Cr ≥150 µmol/l. Cr ≥150 µmol/l was found, as shown in [Table 1](#T0001){ref-type="table"}, to be a highly significant predictive factor for limb loss (*P*= 0.001). Pittet et al. ([@CIT0021]) and Upchurch et al. ([@CIT0026]) showed that elevated CRP levels and elevated Cr levels were useful in signalling severe infection and predicting limb loss. However, a study by Santos et al. ([@CIT0014]) did not find Cr, glucose and WBC levels to be significant risk factors for major amputations.

### Glycosylated hemoglobin \>7.0%

Limb loss occurred in 24.1% of patients with HbA1c \>7.0%. [Table 1](#T0001){ref-type="table"} showed that HbA1c was not found to be a predictive factor for limb loss (*P*\> 0.050). Glycemic control is commonly found to be of key importance to the prevention of major amputations ([@CIT0008], [@CIT0027]), although HbA1c was not found to be a predictive factor in our study.

Conclusion {#S0020}
==========

This is the most comprehensive study about DFIs undertaken in Singapore in recent years and hope that it will provide awareness of the rising rate of diabetes mellitus and its related lower extremity amputations.
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